Chris Fowler Racing to Be Sponsored by Chiron -- Fowler credits use of Chiron’s product TOBI® tobramycin solution for inhalation with keeping him “on track”
Chris Fowler of Chris Fowler Racing is pleased to announce the signing of Chiron Corporation as an official associate sponsor. Chiron BioPharmaceuticals, a business unit of Chiron, produces TOBI® tobramycin solution for inhalation, an inhaled antibiotic indicated for the management of cystic fibrosis (CF) patients. Fowler was diagnosed with CF at six months old, and at age 29, is determined to become a major force in professional racing.
Jacksonville, FL (PRWEB) August 5, 2004
Chris Fowler of Chris Fowler Racing is pleased to announce the signing of Chiron Corporation as an official associate sponsor. Chiron, headquartered in Emeryville, Calif., is a global biotechnology company that addresses human suffering worldwide with more than 50 diverse products to detect, prevent and treat disease.
Chiron BioPharmaceuticals, a business unit of Chiron, produces TOBI® tobramycin solution for inhalation, an inhaled antibiotic indicated for the management of cystic fibrosis (CF) patients with Pseudomonas aeruginosa, a type of bacteria frequently found in the lungs of a person with CF.
CF is a genetic disease that affects approximately 30,000 people in the United States. A defective gene causes the body to produce abnormally thick, sticky mucus that leads to chronic and life-threatening lung infections and impairs digestion.
Fowler was diagnosed with CF at six months old, and at age 29, is determined to become a major force in professional racing. He has used TOBI® to manage his CF since the age of 23.
"I am pleased to have Chiron’s support as a sponsor of Chris Fowler Racing. My dream is to race professionally, and Chiron is helping me achieve this dream. My health regimen that includes the use of TOBI® keeps me physically able to race and remain in good health until a cure for CF is discovered," Fowler said.
For the 2004 season, Fowler is targeting races in the second half of the 2004 American Speed Association (ASA) Series (www. asaracing. com). In its 36th year of operation, ASA is the premier stock car short track racing series in the United States.
FowlerÂ’s previous racing record includes 2nd, 3rd, 4th and 5th place finishes in the 2002-03 Skip Barber Formula Dodge Southern Series. He has pledged to donate ten percent of his race winnings to the CF Foundation, headquartered in Bethesda, Md., to support research towards a cure for CF.
Fowler addressed attendees at the 2004 North American Commercial Meeting of Chiron BioPharmaceuticals held February 9-13, 2004, about living with CF and how TOBI® has improved his life. He will be featured in the 2005 TOBI calendar, which features CF patients from across the country.
More information about Fowler is available at www. fowlerracing. com. More information about TOBI® is available at www. abouttobi. com. For photos relating to this release, please contact Kelly Papinchak at 713-416-2218 or kelly@fowlerracing. com.
# # #
